A phase I open-label study of the safety, tolerability, and pharmacokinetics of pazopanib in combination with irinotecan and cetuximab for relapsed or refractory metastatic colorectal cancer

Jaafar Bennouna, Marion Deslandres, Hélène Senellart, Cécile de Labareyre, Rodrigo Ruiz-Soto, Claire Wixon, Jeff Botbyl, A. Benjamin Suttle, Jean‐Pierre Delord

Investigational New Drugs · 2014 · 26 citations · 24 references

Concepts

References

24